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HFDSUMMARY
Testing the effect of specific macronutrient combinations on
mouse metabolism in vivo, the authors determined that di-
ets pairing starch as carbohydrate with oleate as fat
(42%:42% kcal) induced significant white adipose tissue
pathology and hepatic steatosis compared with other
isocaloric combinations.
BACKGROUND & AIMS: The factors that distinguish
metabolically healthy obesity from metabolically un-
healthy obesity are not well understood. Diet has been
implicated as a determinant of the unhealthy obesity
phenotype, but which aspects of the diet induce dysme-
tabolism are unknown. The goal of this study was to
investigate whether specific macronutrients or macronu-
trient combinations provoke dysmetabolism in the context
of isocaloric, high-energy diets.
METHODS: Mice were fed 4 high-energy diets identical in
calorie and nutrient content but different in nutrient compo-
sition for 3 weeks to 6 months. The test diets contained 42%
carbohydrate (sucrose or starch) and 42% fat (oleate or
palmitate). Weight and glucose tolerance were monitored;blood and tissues were collected for histology, gene expression,
and immunophenotyping.
RESULTS: Mice gained weight on all 4 test diets but differed
significantly in other metabolic outcomes. Animals fed the
starch-oleate diet developed more severe hepatic steatosis than
those on other formulas. Stable isotope incorporation showed
that the excess hepatic steatosis in starch-oleate–fed mice
derived from exaggerated adipose tissue lipolysis. In these
mice, adipose tissue lipolysis coincided with adipocyte necrosis
and inflammation. Notably, the liver and adipose tissue
abnormalities provoked by starch-oleate feeding were repro-
duced when mice were fed a mixed-nutrient Western diet with
42% carbohydrate and 42% fat.
CONCLUSIONS: The macronutrient composition of the
diet exerts a significant influence on metabolic outcome,
independent of calories and nutrient proportions. Starch-oleate
appears to cause hepatic steatosis by inducing progressive adi-
pose tissue injury. Starch-oleate phenocopies the effect of a
Western diet; consequently, it may provide clues to the mecha-
nism whereby specific nutrients cause metabolically unhealthy
obesity. (Cell Mol Gastroenterol Hepatol 2017;4:223–236; http://
dx.doi.org/10.1016/j.jcmgh.2017.04.004)
Keywords: Steatohepatitis; Oleate; Starch; Adipose Tissue.
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1,2Abbreviations used in this paper: CHO, carbohydrate; DNL, de novo
lipogenesis; eWAT, epididymal white adipose tissue; MHO, metaboli-
cally healthy obese; MUO, metabolically unhealthy obese; NK, natural
killer; TG, triglyceride.
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Although obesity is often accompanied by dysmetabolism
and inflammation in the form of insulin resistance, type 2
diabetes, hypertension, and cardiovascular disease, not all
obese individuals display these comorbidities. Experts now
separate obese persons into 2 categories based on the
presence or absence of metabolic derangements: the meta-
bolically healthy obese (MHO) and the metabolically
unhealthy obese (MUO). The stringency by which metabolic
“health” is defined is not yet completely standardized.
Accordingly, somewhere between 10% and 50% of obese
individuals are classified as MHO, whereas the remainder
are considered MUO.3
Hepatic steatosis is an important feature of the MUO
phenotype.4 Scientists have recently reported that hepatic
steatosis predates other features of dysmetabolism in
obesity,5 suggesting it is a predictor of more advanced
metabolic disease. Given the importance of hepatic steatosis
to the definition and possibly the pathogenesis of MUO,
there is great interest in defining the factors that promote
metabolic deterioration in the obese. One variable that has
been scrutinized as a possible determinant of MUO is diet.
Although some large population studies have identified
subtle differences in diet as a determinant of the MUO
phenotype,6,7 others have not been able to detect a differ-
ence in either calorie or nutrient consumption between
MHO and MUO subgroups.8–10 This may be due to the
imperfect quality of dietary data in population studies,
which in general rely on self-report and recall.
Despite the paucity of epidemiologic evidence that diet is
a risk factor for MUO, carefully controlled intervention
studies argue that manipulation of individual nutrients can
impact metainflammation.11–13 Still, it is uncertain whether
specific carbohydrate (CHO)-fat combinations, when tested
within the context of calorically matched diets, have unique
effects on metabolic health over the long term.14,15 The goal
of this study was to determine whether diets similar in
nutrient content to the typical American diet, but differing in
their sources of CHO and fat, exert different effects on the
livers of mice. The results indicate that 4 different dietary
formulas, matched in calories, CHO, and fat content but with
different macronutrient composition, did indeed induce
significantly different degrees of hepatic steatosis over 6
months. The 4 formulas also induced significantly different
degrees of adipose tissue injury and inflammation, and
demonstrated a striking direct relationship between adipose
tissue damage and hepatic lipid accumulation. Surprisingly,
the single macronutrient that promoted the worst metabolic
phenotype in mice was oleate, a monounsaturated fat.
Methods
Animals and Diets
Adult male mice (C57BL/6J and C3H/HeOuJ, The Jackson
Laboratory, Bar Harbor, ME) were used for all studies. Somewere fed standard laboratory chow as a control diet
(PicoLab Diet # 5053, St. Louis, MO). Others were randomly
assigned to 1 of 4 isocaloric high-energy diets comprising
15% kcal protein, 42% kcal CHO, and 42% kcal fat (Dyets,
Inc, Bethlehem, PA) (Table 1). The groups were named for
their primary ingredients: starch-palmitate, sucrose-
palmitate, starch-oleate, and sucrose-oleate. A separate
group of mice was fed a Western diet (TD.88137, Envigo
Teklad, Madison, WI) comprising 42% kcal CHO and 42%
kcal fat of mixed sources. Animals were group-housed with
ad libitum access to food and water and were treated in
accordance with Institutional Animal Care and Use Com-
mittee guidelines at the University of California, San
Francisco.Serum Chemistries
Serum alanine aminotransferase was measured on an
ADVIA 1800 autoanalyzer (Siemens Healthcare Diagnostics,
Deerfield, IL) in the clinical chemistry laboratory at the
Zuckerberg San Francisco General Hospital.Glucose Tolerance Test
Glucose tolerance tests were performed 1 week prior to
the end of each dietary study as previously described.16Measurement of Hepatic Lipids
Lipids were extracted from liver tissue employing the
Folch method.17 Liver triglyceride (TG) was quantified bio-
chemically as described previously.18Histology and Immunohistochemistry
Sections of liver and epididymal white adipose tissue
(eWAT) were stained with H&E and blindly scored by a
pathologist (J.P.G., liver; S.J.C., adipose tissue). Liver sections
were scored for steatosis, ballooning, and inflammation
using the criteria developed by Kleiner et al.19 Adipose tis-
sue was scored for necrosis on a 0 to 3 scale as follows:
0 ¼ scattered crown-like structures only, 1 ¼ focal areas of
necrosis affecting <5% of the total tissue, 2 ¼ 5%–25%
necrosis, 3 ¼ >25% necrosis. Adipose tissue necrosis is
defined as anuclear or disintegrated adipocytes, of varying
size, surrounded by aggregates of inflammatory cells with or
without multinucleate giant cells present.20 Additional sec-
tions of eWAT were subjected to immunohistochemistry for
perilipin 1 (#9349, Cell Signaling Technology, Danvers, MA)
and NKp46 (#137615, Biolegend, San Diego, CA).
Table 1.Dietary Composition
Nutrient (g/kg) Chow
Sucrose
palmitate
Starch
palmitate
Sucrose
oleate
Starch
oleate
Western
diet
Amino acids L-Alanine 11.9 4.5 4.5 4.5 4.5 5.1
L-Arginine, fb 12.9 6.3 6.3 6.3 6.3 6.4
L-Aspartic acid 21.9 11.3 11.3 11.3 11.3 11.7
L-Cystine 3.6 3.7 3.7 3.7 3.7 0.5
L-Glutamic acid 41.8 36.2 36.2 36.2 36.2 35.5
Glycine 9.7 3.1 3.1 3.1 3.1 3.1
L-Histidine, f b 5.3 4.5 4.5 4.5 4.5 4.9
L-Isoleucine 8.6 8.4 8.4 8.4 8.4 9.8
L-Leucine 15.7 15.3 15.3 15.3 15.3 15.6
L-Lysine-HCl 11.8 16.1 16.1 16.1 16.1 13.7
L-Methionine 6.2 2.0 2.0 2.0 2.0 10.5
L-Phenylalanine 9.1 8.7 8.7 8.7 8.7 8.6
L-Proline 13.1 20.4 20.4 20.4 20.4 17.6
L-Serine 9.8 9.4 9.4 9.4 9.4 9.8
L-Threonine 7.8 6.6 6.6 6.6 6.6 7.4
L-Tryptophan 2.4 2.1 2.1 2.1 2.1 2.0
L-Tyrosine 6.0 9.2 9.2 9.2 9.2 9.0
L-Valine 9.7 9.9 9.9 9.9 9.9 11.7
Choline chloride 2.0 2.0 2.0 2.0 2.0 2.0
SUBTOTAL 209.3 179.7 179.7 179.7 179.7 184.9
Carbohydrate Cornstarch 286 — 472.9 — 472.9 150.0
Cellulose 216a 80.0 80.0 80.0 80.0 50.0
Fructose 2.4 — — — — —
Glucose 1.9 — — — — —
Lactose 13.4 — — — — —
Sucrose 32.4 456.9 — 456.9 — 341.5
SUBTOTAL 552.1 536.9 552.9 536.9 552.9 541.5
Fat Saturated fats 7.8 220.6 205.4 19.4 18.1 131.0
Monounsaturated fats 9.7 1.4 1.3 187.1 174.2 57.9
Polyunsaturated fats 32.5 9.0 8.4 24.5 22.8 21.6
Cholesterol 0.1 — — — — 1.5
Main source Soybean oil Tripalmitinb Tripalmitinb High-oleic
sunflower oil
High-oleic
sunflower oil
Anhydrous
milk fat
SUBTOTAL 50.1 231.0 215.1 231.0 215.0 212.0
% kcal Protein 24.5 14.6 15.4 14.6 15.4 15.2
CHO 62.3 42.7 42.5 42.7 42.5 42.7
Fat 13.1 42.7 42.1 42.7 42.1 42.0
aUndefined fiber.
bTripalmitin diets were enriched with safflower oil for essential fatty acid supplementation (reflected in totals).
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Expression
Adipose tissue RNA was isolated using an RNeasy lipid
tissue kit (Qiagen, Germantown, MD). eWAT gene expres-
sion was analyzed using an nCounter mouse immunology
gene expression codeset from NanoString Technologies
(XT_PGX_MmV1_Immunology_KIT, Seattle, WA). The assay
was performed by the Stanford Functional Genome Facility
and data were analyzed using nSolver 2.5 software (Nano-
String Technologies).
Measurement of De Novo Lipogenesis
De novo lipogenesis (DNL) in liver and adipose tissue
was measured by the use of 2H2O labeling combined with
mass isotopomer distribution analysis as described previ-
ously.21,22 For experiments assessing hepatic DNL, animals
received an intraperitoneal bolus of saline prepared with
99% 2H2O (30 mL/kg) 1 day prior to killing and were
placed on drinking water containing 8% 2H2O for 24 h. Forexperiments assessing adipose tissue DNL, different mice
received a comparable loading dose of 2H2O-saline 1 week
prior to euthanasia and were maintained on 8% 2H2O in the
drinking water for 7 days. Labeling periods were longer for
adipose tissue to ensure adequate isotope enrichment of
cellular lipids.23 2H2O incorporation into hepatic or adipose
tissue palmitate was assessed by mass spectrometry and
mass isotopomer distribution analysis calculations were
based on 22 possible sites for deuterium incorporation.Adipose Tissue Lipolysis
eWAT was collected from mice fed experimental diets
for 6 weeks. Tissue fragments (20 to 40 mg) were washed
with cold phosphate-buffered saline and cultured in Dul-
becco’s modified Eagle medium for 1 to 19 hours at 37C,
with or without forskolin (10 mM). The amount of free fatty
acid released into the medium was quantitated (LIP-1-NC,
Zenbio, Research Triangle Park, NC) and normalized per
gram of tissue.
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Cytometry
eWAT was collected and stromal vascular cells were iso-
lated by collagenase digestion. Briefly, fat padswere incubated
with 0.2 mg/mL collagenase NB8 (Crescent Chemical Co,
Islandia, NY) for 60 minutes at 37C and the cell suspension
serially filtered through 100-mm, 70-mm, and 40-mm cell
strainers. After centrifugationat 500 g for 5minutes, cellswere
stained for flow cytometry with the following antibodies from
Biolegend: PerCP-Cy5.5-CD11b (#101228), APC/FIRE-
CD45 (#103154), AF700-Ly-6C (#128024), FITC-NKp46
(#137606), and APC-TCRb (#109212).
Statistical Analysis
All experimental results were compared using 1-way
analysis of variance followed by a Tukey post hoc test, unless
otherwise noted in the figure legends. Statistical analyseswere
performed with Prism 6 software (GraphPad, La Jolla, CA).
Data
All authors had access to the study data and have
reviewed and approved the final manuscript.
Results
A Starch-Oleate Diet Induces More Hepatic
Steatosis Than Do Isocaloric Diets Featuring
Other Nutrients
Mice were fed isocaloric high-energy diets, identical in
nutrient content (42:42:15 CHO:fat:protein) but differing in
macronutrient composition, for 6 months. Initial studies
conducted with 2 strains of mice (C3H and C57BL/6)
revealed that C3H mice developed hepatic steatosis rapidly in
response to high-energy feeding (Figure 1), and thus this
strain was used for all subsequent experiments. All miceFigure 1. Strain-dependent difference in the hepatic
response to high-energy feeding. C3H and C57BL/6 mice
were fed a high-energy diet for various intervals up to 6
months. Graph illustrates liver weight as a percent of body
weight at each interval. Values represent means for n ¼ 2 to 4.consumed similar amounts of food over the study period and
all mice on high-energy diets gained more weight than chow
control mice (Figure 2A and B). Despite this, only mice fed
starch-enriched diets displayed hyperinsulinemia at 6
months (Table 2), and only those fed starch-oleate exhibited
glucose intolerance (Figure 1C). All mice fed high-energy di-
ets developed hepatic steatosis compared to chow control
mice. The degree of steatosis, however, differed among the 4
experimental groups. Mice fed starch-oleate displayed the
worst steatosis, accumulating at least 40% more hepatic lipid
than the other 3 high-energy diet groups (Figure 2D and E).
Starch-oleate–fed mice also showed more evidence of liver
injury than did mice in the other high-energy groups. They
displayed the most hepatocyte ballooning and had the highest
alanine aminotransferase levels of all groups under study
(Table 2); however, no group demonstrated significant
fibrosis by Sirius red staining (data not shown).
Starch-Oleate Feeding Increases Hepatic DNL
and Incorporation of Fat From Adipose Tissue
To determine whether hepatic steatosis in starch-
oleate–fed mice was due to a disproportionate increase in
hepatic DNL, we measured DNL directly by deuterium
incorporation into liver palmitate. DNL was elevated in all
mice fed the experimental diets compared to chow, but
there was no difference among the 4 high-energy groups
(Figure 3A). Instead, the bulk of the palmitate in starch-
oleate–fed livers derived from sources other than DNL
(Figure 3B). The other (unlabeled) sources represented in
Figure 3B include dietary fat and fatty acids from adipose
tissue lipolysis. Because the starch-oleate diet contained
little or no palmitate, the large amount of palmitate in
starch-oleate livers likely derived from adipose tissue
lipolysis.
Because our data suggested adipose tissue lipolysis was
more prominent in mice fed starch-oleate than in other
high-energy diets, we investigated the effect of each diet on
eWAT, the main visceral fat depot in mice. In chow-fed
control mice, eWAT weight measured as a percentage of
body weight increased significantly between 3 weeks and 6
months (Figure 3C). In contrast, eWAT weight percent did
not increase in any of the mice fed high-energy diets; in fact,
eWAT weight percent declined in mice fed oleate-enriched
diets, even dropping below 1% in mice fed starch-oleate
for 6 months. At the 6-month interval, an inverse relation-
ship was noted between eWAT weight and liver weight in
mice from all dietary groups (Figure 3D). Viewing these
results together with the stable isotope incorporation data,
it is evident that DNL and adipose tissue lipolysis both
contribute to hepatic steatosis in response to high-energy
diets but adipose tissue lipolysis is disproportionately
increased in response to a starch-oleate diet.
Starch-Oleate Feeding Induces Histologic and
Functional Changes in eWAT as It Induces
Hepatic Steatosis
Diet-induced obesity is known to cause adipose tissue
necrosis and inflammation. Because starch-oleate feeding
Figure 2. Metabolic and histological features of mice fed chow or custom high-energy diets for 6 months. (A) Average
food intake, reported as g food consumed per gram of body weight per day, measured biweekly over 6 months. (B) Percent
body weight gain over time. (C) Blood glucose levels following administration of 1.5 g/kg glucose intraperitoneally, performed
after 6 months on diet. (D) Liver TG in milligrams per gram of liver. (E) H&E-stained liver tissue was viewed on a Nikon
Microphot FXA microscope (Nikon, Tokyo, Japan) under a 10 objective and photographed using a Spot camera (Spot
Imaging, Sterling Heights, MI). Images were compiled in Photoshop CS6 (Adobe Systems Inc, San Jose, CA). Bar ¼ 100 mm.
Arrows document ballooned hepatocytes. Inset highlights a ballooned cell at 40 magnification. Values represent mean ± SE
for n ¼ 10, performed as replicate experiments of n ¼ 5 each. *P < .05 versus other groups at the same time point. St Ol,
starch-oleate; St Pal, starch-palmitate; Suc Ol, sucrose-oleate; Suc Pal, sucrose-palmitate.
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months, we elected to explore the kinetics of eWAT atrophy
in mice fed this diet over 24 weeks. eWAT mass expanded
slightly during the first 5 weeks of feeding, but then began
to decline and continued a progressive downward trend
through week 24 (Figure 3E). Interestingly, liver mass rose
slightly during the first 5 weeks of feeding and then rose
progressively through week 24 in reciprocal fashion to the
adipose tissue. Photomicrographs of the tissues over the
time course revealed pronounced infiltration of the eWAT
with inflammatory cells as hepatic steatosis progressed
(Figure 3F). Reviewing adipose tissue histology in mice onTable 2.Liver Histological Scores and Serum Values
Steatosis (0–3) Ballooning (0–3)
Chow 0.0 ± 0.0 0.0 ± 0.0
Suc Pal 1.0 ± 0.3 0.0 ± 0.1
St Pal 1.0 ± 0.2 0.0 ± 0.2
Suc Ol 1.0 ± 0.2 1.0 ± 0.3
St Ol 3.0 ± 0.2b 2.0 ± 0.2b
IU, international units; St Ol, starch-oleate; St Pal, starch-palm
aP < .05 versus chow.
bP < .05 versus all other groups.all high-energy diets at 6 months, all groups demonstrated
at least some adipocyte condensation and formation of
crown-like structures, but by far the worst inflammation
was present in the starch-oleate group. Inflammatory cell
infiltration was accompanied by a loss of perilipin 1 staining
indicative of adipocyte necrosis (Figure 4).24 Formal his-
tology scoring confirmed that starch-oleate–fed mice had
significantly more adipose tissue necrosis than did all other
groups (Table 3).
To assess adipose tissue function, we measured DNL and
lipolysis in adipose tissue from mice fed chow and experi-
mental diets. DNL was significantly reduced in mice fedInflammation (0–2) ALT (IU/L) Insulin (ng/mL)
0.0 ± 0.1 47 ± 3 0.52 ± 0.08
0.0 ± 0.1 61 ± 4 0.68 ± 0.13
0.0 ± 0.0 68 ± 4a 1.78 ± 0.24a
0.0 ± 0.1 58 ± 5 0.87 ± 0.37
0.0 ± 0.2 77 ± 4a 1.83 ± 1.2a
itate; Suc Ol, sucrose-oleate; Suc Pal, sucrose-palmitate.
Figure 3. Sources of hepatic lipid at 6 months and changes in eWAT and liver over time in mice fed chow or custom
high-energy diets. (A, B) Hepatic lipid arising from DNL or other sources measured by stable isotope incorporation. Values
represent mean ± SE for n ¼ 10, performed as replicate experiments of n ¼ 5 each. (C) eWAT weight as a percent of body
weight at 3 weeks (wk) and 24 wk following chow or custom diet feeding. Values represent mean ± SE for n ¼ 10, performed as
replicate experiments of n ¼ 5 each. (D) Whole liver and total epididymal fat pads (eWAT) were weighed at 6 months (mo). Liver
weight was plotted against eWAT weight, and a linear correlation was drawn. Values represent each individual animal, n ¼ 10
per diet group. (E) Time course of changes in liver and eWAT weight in starch-oleate–fed mice over 24 weeks. Values represent
means of n ¼ 2 at 6 to 13 wk and n ¼ 10 at 3 wk and 24 wk. (F) H&E-stained liver and eWAT tissue sections were viewed on a
Nikon Microphot FXA microscope under a 10 objective and photographed using a Spot camera. Images were compiled in
Photoshop CS6 (Adobe Systems Inc, San Jose, CA). Bar ¼ 100 mm. *P < .05; #P < .05 for 3 weeks versus 24 wk of the same
diet. St Ol, starch-oleate; St Pal, starch-palmitate; Suc Ol, sucrose-oleate; Suc Pal, sucrose-palmitate.
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Figure 4. eWAT histology in mice fed chow or custom
high-energy diets for 6 months. Adipose tissue sections
were stained with H&E or an antibody against perilipin 1.
Sections were viewed on a Nikon Microphot FXA microscope
under a 10 objective and photographed using a Spot
camera. Images were compiled in Photoshop CS6 (Adobe
Systems Inc, San Jose, CA). Loss of perilipin 1 (brown)
staining in adipocyte membranes is indicative of cell death.
Bar ¼ 100 mm. St Ol, starch-oleate; St Pal, starch-palmitate;
Suc Ol, sucrose-oleate; Suc Pal, sucrose-palmitate.
Table 3.Epididymal Adipose Tissue Histological Scores
eWAT Necrosis (0–3)
Chow 0.9 ± 0.2
Suc Pal 0.8 ± 0.3
St Pal 1.2 ± 0.2
Suc Ol 1.1 ± 0.2
St Ol 2.0 ± 0.2a
St Ol, starch-oleate; St Pal, starch-palmitate; Suc Ol,
sucrose-oleate; Suc Pal, sucrose-palmitate.
aP < .05 versus all other groups.
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signaling an impairment in fat synthesis and storage
(Figure 5A). Adipose tissue lipolysis was similar in all di-
etary groups except mice fed starch-oleate, where it was
increased 2-fold (Figure 5B). The net effect of reduced DNLand enhanced lipolysis in starch-oleate–fed mice would be a
loss of adipose tissue mass, as was observed in vivo
(Figure 3C and E).
To characterize the inflammatory state of adipose tissue
from mice fed experimental diets, we performed tran-
scriptomic profiling using an inflammatory gene array. Gene
expression clustered by diet, with the groups fed oleate
exhibiting the most pronounced proinflammatory profile
(Figure 6A). Several genes up-regulated by starch-oleate
feeding were suggestive of tissue infiltration by macro-
phages, natural killer (NK) cells and lymphocytes
(Figure 6B). One of the most strongly up-regulated genes
was KLRA8, a marker of NK cells.25 Immunohistochemical
staining confirmed that cells expressing the NK marker
NKp46 were more abundant in adipose tissue from starch-
oleate–fed mice than in tissue from mice fed other diets
(Figure 6C). Knowing that adipose tissue dysfunction begins
early in response to high-energy feeding (Figure 3E), we
harvested adipose tissue from mice fed high-energy diets for
6 weeks and extracted stromal vascular cells for immuno-
phenotyping by flow cytometry eWAT (Figure 7). Mice fed
starch-oleate had 5 times more CD45þ cells than did chow
control mice (58,802 ± 5,418 vs 11,447 ± 4,245; P < .001);
they included NK cells, NKþTþ cells, and T cells, as well as
resident and inflammatory macrophages (Figure 7). Mice
fed oleate with sucrose also displayed an increase in adipose
tissue NK cells, but exhibited no change in any other
immune cell populations.
Effects of Starch-Oleate Feeding on Liver
and Adipose Tissue Phenocopy Those of the
Western Diet
The highly defined diets used in this study differ from
mixed-nutrient diets commonly linked to obesity and fatty
liver disease. To determine whether the effects we observed
in response to starch-oleate are generalizable to other for-
mulas, we examined liver and adipose tissue from mice fed a
commercial Western diet for 6 months. Mice fed the West-
ern diet closely resembled those fed starch-oleate in both
liver and adipose tissue pathology. Similar to starch-
oleate–fed mice, Western diet–fed mice developed signifi-
cant hepatic steatosis at 6 months (Figure 8A and B). Similar
to starch-oleate mice, hepatic lipid in Western diet–fed mice
derived in part from DNL, but mostly from other sources
(Figure 8C). Western diet–fed mice also displayed
Figure 5. DNL and lipolysis in eWAT from mice fed chow or custom high-energy diets for 6 weeks. (A) DNL measured in
adipose tissue by stable isotope incorporation over 1 week. (B) Basal lipolysis measured ex vivo in eWAT harvested from mice.
Forskolin-stimulated lipolysis was similar in all groups (not shown). Values represent mean ± SE for n ¼ 10, performed as
replicate experiments of n ¼ 5 each. *P < .05. St Ol, starch-oleate; St Pal, starch-palmitate; Suc Ol, sucrose-oleate; Suc Pal,
sucrose-palmitate.
230 Duwaerts et al Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 2significant eWAT necrosis and atrophy over time (Figure 8A
and D), coincident with low levels of DNL and high levels of
lipolysis similar to starch-oleate–fed mice (Figure 8E and F).
Finally, adipose tissue from Western diet–fed mice demon-
strated an immune profile similar to starch-oleate–fed mice,
with elevated numbers of NK, NKþTþ, and T cells, as well as
resident and inflammatory macrophages (Figure 8G and H).
Overall, the comparable outcomes induced by the starch-
oleate diet and the Western diet indicate that starch-oleate
is sufficient to induce the metabolic derangements of a
more complex diet.Discussion
The experiments in this study underscore that nutrient
composition is as important as nutrient content in deter-
mining the effect of diet on lipid accumulation in the liver.
Using diets with 42% CHO:42% fat, which were designed to
mimic the CHO and fat proportions of the average American
diet, we found that formulas enriched in monounsaturated
fat (oleate) induce more hepatic steatosis than those
enriched in saturated fat (palmitate). These data add to the
existing literature as many epidemiologic and interventional
studies investigating the health effects of dietary fats have
tended to focus on comparisons between CHOs and fats, or
alternatively between saturated and polyunsaturated,
rather than monounsaturated fats.26,27 Studies that have
concentrated specifically on monounsaturated fats have
yielded mixed results.28–30 Our work directly evaluated the
health outcomes induced by defined diets differing only in
their permutation of CHOs and fats. The data demonstrate
that a monounsaturated fat-enriched diet provokes more
hepatic steatosis than a saturated fat-enriched diet, partic-
ularly when combined with a complex CHO such as starch.
Hepatic lipid derives from 3 major sources: dietary fat,
hepatic DNL, and fatty acids released from adipose tissue.31
The fat content of our high-energy diets was identical,
and thus any excess hepatic steatosis induced by thestarch-oleate formula should have come from either exag-
gerated hepatic DNL or increased adipose tissue lipolysis.
All 4 high-energy diets stimulated hepatic DNL far beyond
that of chow-fed mice, but there was no difference in DNL to
distinguish them from each other. Thus, enhanced adipose
tissue lipolysis was the likely reason for the dispropor-
tionate hepatic lipid accumulation in starch-oleate–fed mice,
and this was confirmed experimentally. Oleate-enriched
diets have been reported previously to promote adipose
tissue lipolysis in rats, but only slightly and only in response
to pharmacologic stimulation.32 In our hands, a starch-
oleate diet enhanced basal levels of adipose tissue lipol-
ysis, which over time in vivo led to a significant reduction in
adipose tissue mass. Unlike earlier studies in which mono-
unsaturated fat-enriched diets have been shown to slow
adipose tissue expansion relative to other high-energy
diets,33 our experiments demonstrated that starch-oleate
feeding actually induced progressive necrosis of adipose
tissue. The downstream consequence of this adipose tissue
involution was worsening of hepatic steatosis.
The initial decline in adipose tissue mass in mice fed the
starch-oleate diet was accompanied by evidence of adipose
tissue inflammation. The transcriptomic profile of adipose
tissue predicted a mixed inflammatory infiltrate comprising
NK cells, macrophages, and T lymphocytes, which was
confirmed by flow cytometry. The genomic data also docu-
mented a decline in several adipocyte-specific differentia-
tion markers; this was consistent with the loss of perilipin
by immunohistochemistry. NK cells figured prominently in
the adipose tissue infiltrate, which coincides with recent
evidence indicating a role for NK cells in the initiation of
adipose tissue inflammation in obesity.34,35 Macrophages
and T cells were also increased in numbers in starch-oleate
adipose tissue, possibly as a result of recruitment down-
stream of NK cell activation and infiltration.34,35 Our
experiments did not specifically interrogate for adipose-
resident invariant NK T cells, which have been reported to
have a unique phenotype.36,37
Figure 6. Inflammatory gene expression profile of eWAT in mice fed chow or custom high-energy diets for 6 months. (A)
Heatmap of eWAT inflammatory gene array organized by diet. (B) Select genes for which statistically significant differences in
expression were noted between starch-oleate (St Ol) and all other diets. Values represent fold change relative to the indicated
comparator group; all values surpassed P < .05, for n ¼ 10 performed as replicate experiments of n ¼ 5 each. Complete array
data are in Supplementary Table 1. (C) eWAT immunohistochemistry for NKp46. Arrows highlight positive cells, which are more
abundant in adipose tissue from St Ol–fed mice. Tissue sections were viewed on a Nikon Microphot FXA microscope under a
10 objective and photographed using a Spot camera. Images were compiled in Photoshop CS6 (Adobe Systems Inc, San
Jose, CA). Bar ¼ 50 mm. Cd1d1, CD1d molecule; Gzmb, granzyme b; Icam2, intercellular adhesion molecule 2; Il17ra,
interleukin 17 receptor a; Il21r, interleukin 21 receptor; Il12rb2, interleukin 12 receptor subunit beta 2; Il1a, interleukin 1a; Klra8,
killer cell lectin-like receptor subfamily A, member 8; Pecam1, platelet and endothelial cell adhesion molecule 1; Pparg,
peroxisome proliferator activated receptor gamma; St Pal, starch-palmitate; Suc Ol, sucrose-oleate; Suc Pal, sucrose-
palmitate; Tgfb1, Transforming growth factor beta 1; Tlr5, Toll-like receptor 5; Tlr8, Toll-like receptor 8.
September 2017 Nutrient-Related Variation in Hepatic Steatosis 231Why dietary oleate, and especially the combination of
starch and oleate, would selectively provoke severe adipose
tissue dysfunction is uncertain. Death of adipocytes from
oleate accumulation is unlikely, because unsaturated fatty
acids are not considered lipotoxic toward these cells.38,39
Unsaturated fatty acids are also relatively weak activators
of macrophages40–42; thus, the link between oleate and ad-
ipose tissue necrosis and inflammation is likely indirect.
Oleate could induce an immune response indirectly in adi-
pose tissue by covalently modifying adipocyte proteins to
generate neoantigens.43,44 Although the mechanism by
which oleate damages adipose tissue is currently unknown,
studies in humans demonstrate that accumulation of un-
saturated fatty acids in adipose tissue is associated with
insulin resistance, reduced DNL, and enhanced lipolysis.45,46Thus, oleate loading of adipocytes appears to be an impor-
tant trigger to a decline in adipose tissue mass with resul-
tant hepatic steatosis.
Our observation that a starch-oleate diet induced more
hepatic steatosis and adipose tissue dysfunction than did
other nutrient combinations is seemingly at odds with other
reports that simple sugars and saturated fats have a greater
propensity to induce metainflammation and disease.47,48 In
fact, previous studies from our own laboratory have docu-
mented the potential for diets containing simple sugars and
saturated fats to provoke excess hepatic steatosis and
steatohepatitis.16,49 Notably, our earlier studies combined
nutrients in a 60:20 CHO:fat ratio rather than the 42:42
ratio used in the current experiments. Dietary formulas with
60:20 CHO:fat provoke more hepatic DNL than those with
232 Duwaerts et al Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 242:42 CHO:fat when compared with chow (A. A. Pierce,
2013 and C. C. Duwaerts, 2014 data not shown). Moreover,
in the presence of abundant amounts of simple CHO, even a
small amount of dietary saturated fat can accentuate DNL byinducing the enzymes in the lipogenic pathway.50 The cur-
rent findings emphasize that the same nutrients, when
combined in different proportions, can provoke markedly
different effects on the liver and adipose tissue.
Figure 8. Features of mice fed WD, St Ol, and chow for 6 months. Data for starch-oleate (St Ol) and chow mice are
reproduced from Figures 2 to 5 and Figure 7. (A) Photomicrographs of H&E-stained liver and eWAT. Bar ¼ 100 mm. (B) Liver TG
content. (C) Hepatic lipid (palmitate) originating from DNL or other sources. (D) eWAT weight as a percent of total body weight.
(E) Adipose tissue DNL. (F) Adipose tissue lipolysis ex vivo. (G) Contour plots distinguishing NK cells (NKp46þ,TCRb-), NKþTþ
cells (NKp46þ, TCRbþ), and T cells (NKp46-, TCRbþ) as well as resident macrophages (CD11bþ, Ly6Cint) and infiltrating
macrophages (CD11bþ, Ly6Chi) in eWAT from mice fed a Western diet (WD). (H) Absolute cell numbers of each cell population
based on flow cytometry data. Values represent mean ± SE for n ¼ 10, performed as replicate experiments of n¼5 each.
*P < .05 to all other groups, #P < .05 to chow,
ˇ
P < .05 to St Ol. FFA, free fatty acids; iMACs, infiltrating macrophages; rMACs,
resident macrophages; TCRb, T-cell receptor beta.
September 2017 Nutrient-Related Variation in Hepatic Steatosis 233The diets used in this study were rigorously defined with
a limited number of macronutrients to facilitate the
assessment of individual nutrient effects on liver and adi-
pose tissue. These custom diets have limitations in that they
do not faithfully represent the complex nutrient composi-
tion of the human diet. Still, despite its restrictedFigure 7. (See previous page). Immunophenotyping of eWAT
Stromal vascular cells from adipose tissue were analyzed by flo
CD45þ live cells (B). (A) Top panel: gating strategy for this pop
(NKp46þ,TCRb-), NKþTþ cells (NKp46þ, TCRbþ), and T cells (NK
population. Bottom panel: flow cytometry plots distinguishin
macrophages (CD11bþ, Ly6Chi) in eWAT. (C) Absolute cell num
Values represent mean ± SE for n ¼ 5 mice. *P < .05. CD45, clu
infiltrating macrophages; rMACs, resident macrophages; SSC
palmitate; Suc Ol, sucrose-oleate; Suc Pal, sucrose-palmitate;composition, the starch-oleate diet produced nearly iden-
tical metabolic effects on mice fed as a mixed-nutrient
“Western diet” over a 6-month interval. Although the
Western diet is more nutrient diverse than the starch-oleate
diet is, the 2 formulas have similar caloric densities and
similar proportions of CHO and fat. The fact that starch-in mice fed chow or custom high-energy diets for 6 weeks.
w cytometry after initial gating on CD45þ lymphocytes (A) or
ulation. Bottom panel: contour plots distinguishing NK cells
p46-, TCRbþ) in eWAT. (B) Top panel: gating strategy for this
g resident macrophages (CD11bþ, Ly6Cint) from infiltrating
bers of each cell population based on flow cytometry data.
ster of differentiation 45; FSC-A, forward scatter-area; iMACs,
-A, side scatter-area; St Ol, starch-oleate; St Pal, starch-
TCRb, T-cell receptor beta.
234 Duwaerts et al Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 2oleate phenocopied the effect of the Western diet in mice
provides a strong rationale to further pursue the disease-
promoting potential of this nutrient pair.
The data in this study were generated with C3H mice
rather than the more commonly used C57BL/6 strain. We
used C3H/HeOuJ mice, which, unlike the mutant substrain
C3H/HeJ, exhibit normal Toll-like receptor signaling. We
found in preliminary experiments that C3H/HeOuJ mice
exhibited more rapid hepatic steatosis and adipose tissue
involution than C57BL/6J mice did. Interstrain differences
in dietary responses are known to occur51–53 and provide
additional opportunity for exploration.
In summary, the current study demonstrates that a diet
balanced in CHO and fat but highly enriched in mono-
unsaturated fat can produce pronounced dysfunction of
visceral adipose tissue, resulting in hepatic steatosis. This
corroborates observations in humans, in which excess
accumulation of oleate in adipose tissue coincides with
insulin resistance. Although dietary oleate has been pur-
ported to have many health benefits including a favorable
circulating lipid profile,54 too much monounsaturated fat in
the diet can have significant adverse effects on metabolism.
This discovery calls for close examination of the detrimental
effects of dietary oleate, as well as further efforts to deter-
mine the appropriate balance of nutrient content and
composition to foster metabolic homeostasis.References
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